Hypercholesterolemia

For patients with familial hypercholesterolemia, overeating was connected to a lower quality of life, underscoring the need for a multidisciplinary approach when it comes to treating patients in this population, according to researchers.

Asymptomatic metabolic syndrome at midlife was associated with increased risk and earlier occurrence of CV events and mortality later in life, researchers reported.

Most U.S. adults with coronary artery disease are not meeting guideline-recommended LDL targets, even when prescribed statin therapy, according to an analysis of nationwide survey data.

The National Lipid Association Scientific Sessions will be held today to Sunday and will spotlight statements on nutrition in adults with dyslipidemia, include sessions on the integration of lipid guidelines in clinical practice and more.

About 75% of adults with heterozygous familial hypercholesterolemia do not meet guideline-recommended LDL treatment targets, whereas women with familial hypercholesterolemia are less likely than men to be appropriately treated, data show.

NEW ORLEANS — In a phase 2 trial, an oral PCSK9 inhibitor lowered LDL about the same amount observed with injectable PCSK9 inhibitors for 8 weeks, researchers reported at the American College of Cardiology Scientific Session.

A study published in the European Journal of Preventive Cardiology found that patients with familial hypercholesterolemia may have elevated risk for developing eating disorders.

LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD.

Among younger patients with ACS, approximately one in 11 had familial hypercholesterolemia, researchers reported in The American Journal of Cardiology.

Personalized nutrition interventions led by grocery store dietitians and guided by food purchase data.